Implementation and evaluation of a warfarin dosing service for rehabilitation medicine: Report from a pilot project

Canadian Journal of Hospital Pharmacy

Volumn 59, Issue 3, 2006, Pages 136-147

  Chau, Thomas ^a   Rotbard, Morris ^a   King, Sharon ^a   Munoz Li, Michelle ^a   Leong, Wendy A ^b  

^a University of Toronto McLaughlin Centre and Joint Centre for Bioethics   (Canada)

^b Burnaby Research   (Canada)

Author keywords

Anticoagulation; International normalized ratio; Rehabilitation medicine; Warfarin

Indexed keywords

ALLOPURINOL; ANTIBIOTIC AGENT; FRESH FROZEN PLASMA; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW MOLECULAR WEIGHT HEPARIN; PARACETAMOL; VITAMIN K GROUP; WARFARIN;

ADULT; AGED; ANTICOAGULATION; ARTICLE; BLEEDING DISORDER; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DRUG FATALITY; FEMALE; HEALTH SERVICE; HEMATURIA; HUMAN; INTERNATIONAL NORMALIZED RATIO; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; NOMOGRAM; PATIENT PARTICIPATION; PHARMACIST; PHARMACY; PHYSICIAN; PILOT STUDY; REHABILITATION MEDICINE; RETROSPECTIVE STUDY;

EID: 34249726638     PISSN: 00084123     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004:126(3 Suppl):163S-696S.
2. Schulman S. Care of patients receiving long-term anticoagulant therapy. N Engl J Med 2003;349:675-83.
3. Ansell JE, Buttaro ML, Thomas OV, Knowlton CH. Consensus guidelines for coordinated outpatient oral anticoagulation therapy management. Anticoagulation Guidelines Task Force. Ann Pharmacother 1997;31:604-15.
4. Lodwick AD, Sajbel TA. Patient and physician satisfaction with a pharmacist-managed anticoagulation clinic: implications for managed care organizations. Manag Care 2000;9(2):47-50.
5. Norton JLW, Gibson D. Establishing an outpatient anticoagulation clinic in a community hospital. Am J Health Syst Pharm 1996;53:1151-7.
6. Sunderji R, Campbell L, Shalansky K, Fung A, Carter C, Gin K. Outpatient self-management of warfarin therapy: a pilot study. Pharmacotherapy 1999;19:787-93.
7. Garabedian-Ruffalo SM, Gray DR, Sax MJ, Ruffalo RL. Retrospective evaluation of a pharmacist-managed warfarin anticoagulation clinic. Am J Hosp Pharm 1985;42:304-8.
8. To E, Jackevicius C. Quality improvement initiative for pharmacist-assisted warfarin dosing: implementation and evaluation of a new protocol. Can J Hosp Pharm 2002;55:105-13.
9. Wong W, Norton J, Wittkowsky A. Influence of warfarin regimen type on clinical and monitoring outcomes in stable patients in an anticoagulation management service. Pharmacotherapy 1999;19:3385-91.
10. Chamberlain M, Sageser N, Ruiz D. Comparison of anticoagulation clinic patient outcomes with outcomes from traditional care in a family medicine clinic. J Am Board Fam Pract 2001;14(1):16-21.
11. Sheehan O, Stinson JC, Feely J. Establishing a primary care based anticoagulation clinic. Ir Med J 2000;93(2):45-8.
12. Willey ML, Chagan L, Sisca TS, Chapple KJ, Callaha AK, Crain JL, et al. A pharmacist-managed anticoagulation clinic: six-year assessment of patient outcomes. Am J Health Syst Pharm 2003;60:1033-7.
13. Chiquette E, Amato MG, Bussey HI. Comparison of an anticoagulation clinic with usual medical care. Arch Intern Med 1998;158:1641-7.
14. Conte RR, Kehoe WA, Nielson N, Lodhia H. Nine-year experience with a pharmacist-managed anticoagulation clinic. Am J Hosp Pharm 1986;43:2460-4.
15. Wilt VM, Gums JG, Ahmed OI, Moore LM. Outcome analysis of a pharmacist-managed anticoagulation service. Pharmacotherapy 1995;15:732-9.
16. Lee YP, Schommer JC. Effect of a pharmacist-managed anticoagulation clinic on warfarin-related hospital admissions. Am J Health Syst Pharm 1996;53:1580-3.
17. Wilson SJ, Wells PS, Kovacs MJ, Lewis GM, Martin J, Burton E, et al. Comparing the quality of oral anticoagulant management by anticoagulation clinics and by family physicians: a randomized controlled trial. CMAJ 2003;169:293-8. Erratum in: CMAJ 2004; 170:451.
18. Foss MT, Schoch PH, Sintek CH. Efficient operation of a high-volume anticoagulation clinic. Am J Health Syst Pharm 1999;56:443-9.
19. Norton JL, Gibson DL. Establishing an outpatient anticoagulation clinic in a community hospital. Am J Health Syst Pharm 1996;53:1151-7.
20. Leong W. Burnaby Hospital warfarin dosing service. Burnaby Hosp Pharm Bull 1994 Jun;1-2.
21. Leong W. Community pharmacists managing warfarin therapy. Can Pharm J 2002;35(8):14-5.
22. Leong W. Patient-centred warfarin dosing service [lecture]. American Society of Health-System Pharmacy Midyear Conference; 1995 Dec; Las Vegas (NV).
23. Jaffer A, Bragg L. Practical tips for warfarin dosing and monitoring. Cleve Clin J Med 2003;70:361-71.
24. Oertel LB. Anticoagulation services: quality improvement direction pursuing a certification process. Anticoagulation Provider Certification Working Group. J Thromb Thrombolysis 1999;7:153-6.
25. Beyth RJ, Quinn LM, Landefeld CS. Prospective evaluation of an index for predicting the risk of major bleeding in outpatients treated with warfarin. Am J Med 1998;105(2):91-9.
26. Poli D, Antonucci E, Lombardi A, Boddi V, Gensini GF, Abbate R, et al. Low rate of bleeding and thrombotic complications of oral anticoagulant therapy independent of age in the real-practice of an anticoagulation clinic. Blood Coagul Fibrinolysis 2003;14:269-75.
27. Levine MN, Raskob G, Landefeld S, Keaton C. Hemorrhagic complication of anticoagulant treatment. Chest 2001;119(1 Suppl): 108S-121S.
28. Hirsh J, Fuster V, Ansell J, Halperin JL. American Heart Association/ American College of Cardiology Foundation guide to warfarin therapy. Circulation 2003;107:1692-711.
29. Libby E, Garcia D. A survey of oral vitamin K use by anti-coagulation clinics. Arch Intern Med 2002;162:1893-6.
30. Hirsh J, Dalen J, Anderson DR, Poller L, Bussey H, Ansell J, et al. Oral anticoagulation: mechanism of action, clinical effectiveness, and optimal therapeutic range. Chest 2001;119(1 Suppl): 8S-21S.
31. Ansell J, Hirsh J, Dalen J, Bussey H, Anderson D, Poller L, et al. Managing oral anticoagulant therapy. Chest 2001;119:22S-38S.
32. Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm 1990;47:533-43.
33. Leong W. Anticoagulation: opportunities for community pharmacists. Pharm Pract 2004 Nov. 9 p.
34. Roberts G, Helboe T, Nielsen CB, Gallus AS, Jensen I, Cosh DG, et al. Assessment of an age-adjusted warfarin initiation protocol. Ann Pharmacother 2003;37:799-803.
35. Wittowsky, AK. Warfarin pharmacology. In: Oertel L, editor. Managing oral anticoagulation therapy - clinical and operational guidelines. Seattle (WA): Aspen Publishers Inc; 2001. p. 1-12.
36. Bungard TJ, Ghali WA, McAlister FA, Buchan AM, Cave AJ, Hamilton PG, et al. The relative importance of barriers to the prescription of warfarin for nonvalvular atrial fibrillation. Can J Cardiol 2003;19:280-4.
37. Heidinger KS, Bernardo A, Taborski U, Muller-Berghaus G. Clinical outcome of self-management of oral anticoagulation in patients with atrial fibrillation or deep vein thrombosis. Thromb Res 2000;98:287-93.
38. Eikelboom JW, Quinlan DJ, Douketis JD. Extended-duration prophylaxis against venous thromboembolism after total hip or knee replacement: a meta-analysis of the randomised trials. Lancet 2001;358:9-15.
39. Hull R, Raskob G, Pineo G, Rosenbloom G, Evans W, Mallory T, et al. A comparison of subcutaneous low-molecular-weight-heparin with warfarin sodium for prophylaxis against deep-vein thrombosis after hip or knee implantation. N Engl J Med 1993;329:1370-6.
40. Leong WA. Outpatient anticoagulation: innovative strategies and point of care INR testing. In: Vossoughi J, Fareed J, Mousa SA, Karanian JW, editors. Thrombosis research and treatment: bench to bedside. Washington (DC): Medical and Engineering Publishers Inc; 2004. p. 47-64.
41. Leong WA. Pharmaceutical guidelines for new anticoagulant and antithrombotic agents. In: Vossoughi J, Fareed J, Mousa SA, Keranian JW, editors. Thrombosis research and treatment: bench to bedside. Washington (DC): Medical and Engineering Publishers Inc; 2004. p. 141-6.